Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02565732 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis
A Phase 2 study of Hyperhidrosis, sponsored by Revance Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 67
- Enrollment target
- 1
- Study location
NCT02565732 is a Phase 2 study of Hyperhidrosis that has completed, run by Revance Therapeutics. The registered enrollment target is 67 participants, below the 91-participant average among 8 other Hyperhidrosis trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02565732, a Phase 2 study of Hyperhidrosis, has completed, sponsored by Revance Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 67 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a safety and efficacy study of botulinum toxin type A in subjects with primary axillary hyperhidrosis.
Conditions Studied
Interventions
- BIOLOGICAL Botulinum toxin type A
- BIOLOGICAL Placebo comparator
Study Locations (1)
California
- - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02565732
The ClinicalTrials.gov registry entry for NCT02565732 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 91-participant average among 8 other Hyperhidrosis trials with a reported enrollment target (26% lower). The listed sponsor is Revance Therapeutics, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hyperhidrosis appearing as the primary indexed condition, and to 2 interventions - of which Botulinum toxin type A is the first listed.
NCT02565732 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02565732 about?
NCT02565732 is a clinical study titled "Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis". This is a safety and efficacy study of botulinum toxin type A in subjects with primary axillary hyperhidrosis.
What is the current status of trial NCT02565732?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 67 participants. The study started on 2015-09. Estimated completion is 2016-01.
What conditions does trial NCT02565732 study?
This clinical trial studies the following conditions: Hyperhidrosis.
What interventions are being tested in trial NCT02565732?
The interventions under investigation include: Botulinum toxin type A (BIOLOGICAL), Placebo comparator (BIOLOGICAL).
Who is sponsoring clinical trial NCT02565732?
This trial is sponsored by Revance Therapeutics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02565732 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperhidrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary Hyperhidrosis
COMPLETED · Phase 2
-
A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis
COMPLETED · Phase 2
-
A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects
COMPLETED · Phase 2
-
An Open Label Study for Palmar Hyperhydrosis
COMPLETED · Phase 2
-
Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis
COMPLETED · Phase 2
-
Botulinum Toxin Therapy in Hidradenitis Suppurativa
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.